Terms And Conditions
  1. Home
  2. Terms And Conditions
Arovella Therapeutics Limited (ASX: ALA): Ful...
By ACE Investors / 11 Mar 2025
Read More
Aroa Biosurgery Limited (ASX: ARX) – The fi...
By ACE Investors / 11 Mar 2025
Read More
Compumedics Limited (ASX: CMP): Delivering ag...
By ACE Investors / 04 Mar 2025
Read More
Nova Eye Medical Limited (ASX: EYE): Delivere...
By ACE Investors / 04 Mar 2025
Read More
Cynata Therapeutics Limited (ASX: CYP): Well ...
By ACE Investors / 03 Mar 2025
Read More
Next Science Limited (ASX: NXS): Driving the ...
By ACE Investors / 27 Feb 2025
Read More
West Pharmaceutical Services Inc. (NYSE: WST)...
By ACE Investors / 26 Feb 2025
Read More
Mesoblast Limited (ASX: MSB): Raised A$ 160 m...
By ACE Investors / 24 Feb 2025
Read More
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN): ...
By ACE Investors / 21 Feb 2025
Read More
Maximus Inc. (NYSE: MMS): The divestiture of ...
By ACE Investors / 20 Feb 2025
Read More
Tissue Repair Limited (ASX: TRP) – Opportun...
By ACE Investors / 20 Feb 2025
Read More
Artrya Limited (ASX: AYA): Considerable momen...
By ACE Investors / 14 Feb 2025
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2025 ACE Investors. All Right Reserved. Design by Ace Investors